Still on life support. Need to have a massive increase in...

Still on life support. Need to have a massive increase in revenue next quarter if there is going to be an increased spend on R&D, advertising and extra sales staff on top of the existing loss. No mention of the 17 uni hospitals or revenue from the 17 uni hospitals probably means that deal was terminated. China completely off the radar now. Not sure how they can talk about acquisitions with barely enough money to operate for a year. Lots of promises that need to come true or they will be stuck in the death spiral of continuously raising funds and further dilution.